ISRG, has launched its Da Vinci 5 robotic system, adding new workflow and data capabilities to the operating room. The company is integrating artificial intelligence across its platforms to support ...

The stock has averaged annual gains of nearly 25% over the past decade.

THOMASVILLE — Archbold Pulmonology offers patients state-of-the-art technology with the Intuitive Ion robotic bronchoscopy ...

Intuitive Surgical (NasdaqGS:ISRG) reported 19% year-over-year revenue growth in fiscal 2025 Q4. Growth was driven by higher procedure volumes and increased placements of da Vinci robotic systems. The ...

Intuitive Surgical faces continued challenges in Asia. The company's Ion system replacements are also declining, with lower da Vinci procedure volume growth projected for 2026. However, the value of ...

Intuitive Surgical looks like a long-term buy: strong Da Vinci 5 adoption, expanding FDA use cases, and multiyear-low valuation. Click here to read more.

Intuitive reported adjusted earnings per share of $2.53, beating the consensus estimate of $2.26. In addition, the company reported revenue of $2.86 billion, beating the consensus estimate of $2.74 ...

ISRG has lost 13% in three months, but strong da Vinci 5 adoption and rising procedures raise a bigger question: is this ...

Gross profit, income from operations, net income attributable to Intuitive Surgical, Inc., and net income per diluted share attributable to Intuitive Surgical, Inc. are reported on a GAAP and non-GAAP ...

Macworld highlights five advanced Apple Pencil Pro features including customizable squeeze gestures, Find My integration, and ...